ÂÜÀòÂÒÂ×

Oliver Sartor

Scientific Advisor at Clarity Pharmaceuticals

Professor Sartor is a medical oncologist and an internationally recognised expert in prostate cancer. He is the Laborde Professor for Cancer Research, Medical Director of the Tulane Cancer Center, and Assistant Dean for Oncology at Tulane University School of Medicine in New Orleans, Louisiana.

Professor Sartor is a past member of the Board of Scientific Counselors (Clinical Sciences and Epidemiology) at the National Cancer Institute and previously served as Chairman of the Prostate Cancer Integration Panel for the US Department of Defense. Professor Sartor has chaired five Data Monitoring Committees for Phase III trials that lead to FDA approval. He is medical oncology chair of the Genitourinary committee of NRG Oncology.

Professor Sartor received his Doctor of Medicine from Tulane University with honours in 1982. After his internship at the University of Pennsylvania, he trained in Internal Medicine at Tulane Medical School. After completing his fellowship at the National Cancer Institute in Bethesda, Maryland in 1989, he served until 1993 as a Senior Investigator at the National Cancer Institute with a focus on novel therapeutics for advanced prostate cancer patients.